webleads-tracker

Beefing up safeguards against corruption: Where is the medtech industry in 2015?

Pharma Compliance Info Beefing up safeguards against corruption: Where is the medtech industry in 2015? Eucomed-MedTech   Carolyn M. Bruguera, General Counsel and Vice President of Consulting Services, R-Squared Services and Solutions, Inc.
In light of enforcement trends, compliance officers around the world are beefing up safeguards against corruption by third party intermediaries. For many, the task has been daunting. A large company may have hundreds or even thousands of distributors and sales agents around the world; in some cases just identifying them and implementing written contracts has been a massive undertaking. Small companies have fewer intermediaries, but also have fewer resources for managing their overseas agents and distributors.
So where are we today? The task remains monumental, but companies now have much more guidance available. The US Department of Justice and the UK Ministry of Justice have both released anticorruption guidance documents that provide high-level guidance on screening of distributors and agents. For the medical technology industry, Eucomed and AdvaMed have developed joint guidance for third party sales and marketing intermediary (SMI) relationships and additional tools for educating SMIs.
To read the article by Carolyn M. Bruguera

Check Also

Pharma Compliance Info EDMA and Eucomed Adopt Code of Business Practice Brings Changes to Medical Congresses Eucomed-MedTech

EDMA and Eucomed Adopt Code of Business Practice Brings Changes to Medical Congresses

By Thomas Sullivan – Policy & Medicine Members of both the European Diagnostic Manufacturers Association …

X